Pre-operative Ca 125 (mean±SD (range)) | 532±710 (6–1379) |
Ascitis (mean±SD (range)); mL | 400±978.5 (0–3000) |
Approach, n (%) | |
Laparoscopy | 3 (30) |
Laparotomy | 7 (70) |
Main tumor size (mean±SD (range)); mm | 162±66 (75–250) |
Intra-operative complication, n (%) | |
Vascular injury | 1 (10) |
Bowel injury | 0 (0) |
Bladder/ureteral injury | 0 (0) |
Surgical time (mean±SD (range)); min | 262±49 (210–305) |
Point of injection, n (%) | |
Utero-ovarian ligament stump | |
Not possible (previous hysterectomy) | 2 (20) |
Unilateral | 7 (70) |
Bilateral | 1 (10) |
Infundibulo-pelvic ligament stump | |
Unilateral | 8 (80) |
Bilateral | 2 (20) |
Sentinel lymph node detection tracer rate, n (%) | |
Tc99 | 10 (100) |
Indocyanine green | 9 (90) |
Migration, n (%) | |
Pelvic and/or para-aortic | 10 (100) |
Pelvic unilateral | 7 (87.5) |
Para-aortic | 7 (70) |
Detection time after injection (mean±SD (range)); min | 54±31 (25–120) |
No. of sentinel lymph nodes harvested (mean±SD (range)) | |
Pelvic and/or para-aortic | 2.55±1.6 (1–5) |
Pelvic | 1.86±1.35 (0–4) |
Para-aortic | 1.50±1.41 (0–4) |